mtm laboratories appoints Bob Silverman as CEO


Heidelberg, Germany; July 1, 2008- mtm laboratories, a privately held biotech company globally developing, manufacturing and commercializing in vitro diagnostics for cervical cancer screening, today announced that it has appointed Bob Silverman as its new CEO. Mr Silverman has been the mtm’s Chief Commercial Officer and the President of the mtm US subsidiary since mid 2005.

Dr Gerald Möller, Chairman of mtm laboratories’ supervisory board commented:

“Bob joined us at a pivotal point when mtm was preparing to bring its first products to the market and has played a key role in the successful commercialization of CINtec® Histology, CINtec® Cytology and the Cervatec™ Assay. His contributions have been crucial to the evolution of mtm into an integrated, global operation. We are confident that he possesses the skills and the leadership qualities to take mtm to the next stage in the development and commercialization of mtm’s products.”

Bob Silverman, new Chief Executive Officer of mtm laboratories, commented on his appointment: "I am honored to be stepping into the role of CEO at mtm laboratories. And, I am appreciative of the role that Dr. Pack has played in bringing mtm and its technologies from groundbreaking discovery right up to commercialization.”

Dr. Peter Pack, who hands over as CEO to Bob Silverman, added:
“Over the past few years, mtm laboratories has emerged as a fully integrated diagnostics company. Bob brings a strong commercial dimension and international leadership to the Company, and I wish him and mtm every success.”

Heidelberg will continue to be the Company’s headquarters though Mr Silverman is based at the US subsidiary in Westborough, Massachusetts.

mtm laboratories AG is an ISO 9001 and ISO 13485 certified developer and manufacturer of In-Vitro Diagnostic Devices (IVDD) for use in the early detection and diagnosis of cervical cancer. The Company operates on a global basis with headquarters in Heidelberg, Germany and subsidiaries in the United States, France, Italy and Spain. Further information can be found at: www.mtmlabs.com.

 

Further Information:
Bob Silverman CEO mtm laboratories AG t: +1 508 366 8334 e: contact@mtmlabs.com	Dr. Douglas Pretsell Account Director, Munich Bureau Chief College Hill t : +49 (0)89 57 00 18 06 e: douglas.pretsell@collegehill.com

Notes for Editors


Biography of Bob Silverman

Bob Silverman was appointed CEO of mtm laboratories in July 2008 after having served as Chief Commercial Officer and President of the mtm US subsidiary since mid 2005. Prior to that, Mr. Silverman had provided strategic management consulting services to mtm and other companies in the life science field through his own company, RS Consulting. Before he formed RS Consulting in 2003, Mr. Silverman served as the Senior Vice President of Commercial Operations for ViaCell, Inc., a biotechnology company focused on the application of human cells as medicine in the treatment of human disease. From 1996-2001, Mr. Silverman held several senior executive positions with Cytyc Corporation, including Vice President of International and Vice President of Marketing. Cytyc is a leading medical device company focused on women´s health. In addition, Mr. Silverman has held senior management positions with Pasteur-Merieux Connaught, now a division of Sanofi Aventis, and Abbott Laboratories Pharmaceutical Products Division. Mr. Silverman holds a BSc degree in Pharmacy from the University of Michigan and a Masters in Management, Marketing & Finance from the J.L. Kellogg Graduate School of Management, Northwestern University.